0000899243-23-014883.txt : 20230608
0000899243-23-014883.hdr.sgml : 20230608
20230608163706
ACCESSION NUMBER: 0000899243-23-014883
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230607
FILED AS OF DATE: 20230608
DATE AS OF CHANGE: 20230608
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Harwin Peter Evan
CENTRAL INDEX KEY: 0001663607
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38443
FILM NUMBER: 231002465
MAIL ADDRESS:
STREET 1: 2001 MARKET STREET
STREET 2: SUITE 2500
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cogent Biosciences, Inc.
CENTRAL INDEX KEY: 0001622229
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465308248
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 275 WYMAN STREET
STREET 2: 3RD FLOOR
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-945-5576
MAIL ADDRESS:
STREET 1: 275 WYMAN STREET
STREET 2: 3RD FLOOR
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: Unum Therapeutics Inc.
DATE OF NAME CHANGE: 20180402
FORMER COMPANY:
FORMER CONFORMED NAME: Unum Therapeutics, Inc.
DATE OF NAME CHANGE: 20141014
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-07
0
0001622229
Cogent Biosciences, Inc.
COGT
0001663607
Harwin Peter Evan
C/O COGENT BIOSCIENCES, INC.
275 WYMAN STREET, 3RD FLOOR
WALTHAM
MA
02451
1
0
0
0
0
Stock Option (Right to Buy)
11.70
2023-06-07
4
A
0
36700
0.00
A
2033-06-07
Common Stock
36700
36700
D
This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2024 Annual Meeting of Stockholders.
Under the Reporting Person's arrangement with Fairmount Funds Management LLC (the "Adviser"), the Reporting Person holds the option for one or more investment vehicles managed by the Adviser (each, a "Fairmount Fund"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received from the option for the benefit of such Fairmount Fund. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock.
/s/ Evan D. Kearns, Attorney-in-Fact
2023-06-08